PROKIDNEY CP (PROK)
(Delayed Data from NSDQ)
$2.71 USD
+0.18 (7.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.72 +0.01 (0.37%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$2.71 USD
+0.18 (7.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $2.72 +0.01 (0.37%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth A Momentum C VGM
Zacks News
Here's Why ProKidney Corp. (PROK) Is a Great 'Buy the Bottom' Stock Now
by Zacks Equity Research
ProKidney Corp. (PROK) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
After Plunging -37.39% in 4 Weeks, Here's Why the Trend Might Reverse for ProKidney Corp. (PROK)
by Zacks Equity Research
The heavy selling pressure might have exhausted for ProKidney Corp. (PROK) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
ProKidney Corp. (PROK) Loses -54.93% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
by Zacks Equity Research
ProKidney Corp. (PROK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.